Publication | Closed Access

A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor

Tat Hiv-1 InhibitorMedicinal ChemistryDrug DesignMedicineNatural SciencesAntiviral Drug DevelopmentStructure-based Drug DesignMolecular BiologyRational Drug DesignResistance Mutation (Virology)Possible ImprovementDrug DevelopmentHivPharmacologyAntiviral CompoundDrug Discovery